• Search
  • Advanced Search
Clin Mol Hepatol > Accepted Articles
Editorial
Personalized Approaches to the Treatment of Hepatocellular Carcinoma Using Immune Checkpoint Inhibitors
Naoshi Nishida
Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, 377-2 Ohno-Higashi Osaka-Sayama, 589-8511, Japan
Correspondence :  Naoshi Nishida ,
Tel: +81-72-366-0221 (Ext. 3525), Fax: +81-72-367-2880, Email: naoshi@med.kindai.ac.jp
Received: September 1, 2024   Accepted: September 3, 2024
TOOLS
METRICS Graph View
  • 1 Crossref
  •  0 Scopus
  • 211 View
  • 20 Download
ORCID iDs

Naoshi Nishida
https://orcid.org/0000-0002-9111-5668

Related articles

Correspondence on Letter regarding “Personalized Approaches to the Treatment of Hepatocellular Carcinoma Using Immune Checkpoint Inhibitors”

Criteria and prognostic models for patients with hepatocellular carcinoma undergoing liver transplantation

Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma2023 October;29(4)

Recent advances in the management of hepatocellular carcinoma2024 January;30(1)

Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison2023 April;29(2)

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 834
TOTAL : 2102433
Close layer